Page 80 - UNAM Virtual Graduation 2020 e-Book
P. 80

FACULTY OF HEALTH SCIENCES
          SCHOOL OF PUBLIC HEALTH


          DOCTOR OF PHILOSOPHY IN PUBLIC HEALTH

          CANDIDATE: SALVATORY Magesa Emmanuel






          CURRICULUM VITAE

          Magesa Emmanuel Salvatory was born in Tanzania. He matriculated with
          an Exemption from Caprivi Secondary School. His qualifications include
          Bachelor of Pharmacy from the University of Dar es Salaam; and a Master in
          Public Health from the University of Namibia. His professional career includes
          working as a pharmacist at public health facilities in Tanzania and Namibia in different positions, as well
          as independent researcher. While his academic experience includes part time lecturer, School of Nursing
          at University of Namibia, Lecturer at Welwitchia University. His research interest incorporates stock levels
          modeling and implementation.

          CANDIDATE’S DISSERTATION

          MODELING STOCK LEVELS OF MALARIA RAPID DIAGNOSTIC TEST KITS AND NEVIRAPINE SYRUP IN OSHANA
          REGION, NAMBIBIA.

          The doctoral study was undertaken and completed under the supervision of Prof. Dr. Honore Kabwebwe
          Mitonga of the University of Namibia as Main-Supervisor and Dr. Penehafo Angula from the University of
          Namibia as Co-Supervisor.

          The candidate investigated a potential model of estimating stock levels of malaria test kit and Nevirapine
          syrup in public health facilities in Oshana region Namibia. The study was based on the fact that Malaria and
          HIV/AIDS are two most widely spread diseases in Sub-Saharan Africa. The co-infection is very common in the
          region, especially in unstable malaria transmission areas with the prevalence of 29.9 - 40%. In Namibia these
          two diseases are common in northern eastern regions, which are unstable malaria transmission areas. These
          two diseases affect poorer segments of the population. Individually and biologically Malaria increases viral
          load of HIV people. The severity of malaria is more in pregnant women and children as well as people living
          with HIV. Equity, access of malaria diagnostic test kits and NVP syrup is critical to control these two epidemic
          diseases. Given the nature of current conditions, justification exists for a study to develop and demonstrate
          a mathematical modeling of estimating stock levels, which can establish parameters to prevent stock-outs
          of malaria rapid diagnostic test kit (mRDT) and Nevirapine Syrup (NVP syrup). The study adopted a mixed-
          method design in order to provide a broader perspective of modeling of stock levels in public health facilities,
          which underpins the delivery of mRDT for testing malaria and NVP syrup for PMTCT. In its quantitative aspect,
          the study adopted a descriptive approach to acquire data from a period of five years retrospectively, in this
          case 2012 to 2016 inclusive. Data were mainly obtained from Syspro, DHIS and EDT softwares. The data were
          analysed using SPSS version 23 software, in which time series analysis was applied to determine forecasted
          consumption of mRDT and NVP syrup. The correlation coefficient and Binary logistic regression were used
          to identify factors associated with stock-out of mRDT and NVP syrup. Mathematical models of stock levels
          were developed and validated. The findings showed that due to seasonal variation and other unforeseen
          variables, the consumption of mRDT and NVP syrup in public health facilities is increasing every quarter,
          while delivery lead time being a main factor and predictor of stock out. The model developed found to
          have predictive accuracy of more than 70% in estimating stock levels. The use of this supply models will curb
          unnecessary costs due to irregular orders.

          Furthermore, the model will contribute to the prevention of stock out and diseases control. It is a
          recommendation that similar models should be developed for other medicines such as anti TB, other ARVs
          and antihypertensive drugs.




             80
   75   76   77   78   79   80   81   82   83   84   85